Skip to main content

Table 5 Life-threatening bleeding

From: Analysis of cardiovascular mortality, bleeding, vascular and cerebrovascular events in patients with atrial fibrillation vs. sinus rhythm undergoing transfemoral Transcatheter Aortic Valve Implantation (TAVR)

Follow-up Total population (n = 257) SR-group(n = 148) AF-group(n = 109) p Value OR (95% CI)
30 days 7.4% (19/257) 4.1% (6/148) 11.9% (13/109) 0.028 3.21 (1.18–8.72)
3 months 7.8% (20/257) 4.7% (7/148) 11.9% (13/109) 0.057 2.73 (1.05–7.09)
6 months 8.2% (20/241) 5.0% (7/137) 12.5% (13/104) 0.057 2.69 (1.04–7.01)
12 months 9.0% (20/219) 5.6% (7/124) 13.5% (13/95) 0.057 2.66 (1.02–6.96)
  1. Shows the life-threatening bleeding events of all patients and of the two groups during the course of the follow-up period. The parentheses list the number of life-threatening bleeding events and the number of patients available for analysis
  2. Patients with AF showed nearly three times more life-threatening bleeding events than patients with SR. This result corresponds to the rates and the temporal development of major vascular complications. Most of the life-threatening bleeding occurred peri-precidually and during initiation of oral anticoagulation or dual anti-platelet therapy. Thereafter, no significant differences were determined